CG
IONS icon

Cutler Group’s Ionis Pharmaceuticals IONS Stock Holding History

Cutler Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$4K – 4785
2022
Q3 		$4K Hold
100
– – ﹤0.01% 3794
2022
Q2 		$3K Sell
100
-2,900
-97% -$109K ﹤0.01% 4058
2022
Q1 		$111K Sell
3,000
-1,290
-30% -$42.2K 0.01% 1618
2021
Q4 		$130K Buy
4,290
+3,490
+436% +$110K 0.01% 1651
2021
Q3 		$26K Hold
800
– – ﹤0.01% 3106
2021
Q2 		$31K Buy
+800
New +$31.3K ﹤0.01% 2901
2019
Q1 		– Sell
-100
Closed -$6.45K – 4375
2018
Q4 		$5K Sell
100
-500
-83% -$25.5K ﹤0.01% 2929
2018
Q3 		$30K Buy
600
+270
+82% +$12.7K ﹤0.01% 1966
2018
Q2 		$13K Buy
330
+230
+230% +$10.2K ﹤0.01% 2480
2018
Q1 		$4K Sell
100
-9,897
-99% -$503K ﹤0.01% 3406
2017
Q4 		$502K Sell
9,997
-6,544
-40% -$359K 0.02% 544
2017
Q3 		$838K Buy
16,541
+6,294
+61% +$330K 0.03% 413
2017
Q2 		$521K Sell
10,247
-4,636
-31% -$216K 0.02% 670
2017
Q1 		$598K Sell
14,883
-14,829
-50% -$666K 0.02% 573
2016
Q4 		$1.42M Sell
29,712
-453
-2% -$17.9K 0.05% 291
2016
Q3 		$1.1M Buy
30,165
+1,325
+5% +$41.5K 0.05% 295
2016
Q2 		$671K Sell
28,840
-2,588
-8% -$83.5K 0.03% 440
2016
Q1 		$1.27M Sell
31,428
-23,928
-43% -$972K 0.08% 208
2015
Q4 		$3.43M Buy
+55,356
New +$2.99M 0.19% 81

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutler Group's IONS Position: Q4 2022 in Review

Cutler Group sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 100 shares — an estimated $4K sold.

Cutler Group first reported a position in IONS in Q4 2015 and held it in 19 quarters. The position peaked at $3.43M in Q4 2015. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

  • Cutler Group reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 100 Ionis Pharmaceuticals shares in Q4 2022, an estimated $4K.
  • Cutler Group first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 19 quarters.
  • Cutler Group's Ionis Pharmaceuticals position peaked at $3.43M in Q4 2015.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.